Allergychoices, Inc. began in 2000 as the first dedicated education, advocacy, and networking resource for patients and physicians who were interested in sublingual immunotherapy to treat allergic disease. Today, we’ve grown to be a leading healthcare services company that provides tools that enable physicians to provide sublingual immunotherapy and gives allergy sufferers information and access to practices offering sublingual immunotherapy.
These practices base their treatment on the La Crosse Method™ Practice Protocol developed by our founder, Dr. David Morris (1929-2017), and his physician partners at Allergy Associates of La Crosse in Wisconsin. Internationally recognized as a pioneer in sublingual immunotherapy, Dr. Morris began publishing papers in medical literature on sublingual immunotherapy in 1969. To date, the clinic and physicians working with Allergychoices have helped more than 195,000 patients’ live healthier lives.
Today, partners at Allergy Associates of La Crosse and physicians around the country continue to pave the way for more patients to benefit from innovations made in the Wisconsin clinic.